Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity Hazards Identification
Home > cis-13-Docosenoic acid > cis-13-Docosenoic acid(112-86-7)

cis-13-Docosenoic acid(112-86-7)

Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity Hazards Identification

Product Identification

Product Name
cis-13-Docosenoic acid
Synonyms
(Z)-Docos-13-enoic acid
cis-13-Docosenoic acid
delta 13:14-Docosenoic acid
delta(13)-cis-Docosenoic acid
Hystrene 2290
Z-13-Docosenoic acid
CAS
112-86-7
Formula
C22H42O2
Molecular Weight
338.57
EINECS
204-011-3
Merck
13,3707
Beilstein/Gmelin
1728049
Beilstein Reference
4-02-00-01676

Physical and Chemical Properties

Appearance
White crystalline solid.
Solubility in water
Insoluble
Melting Point
33.8
Boiling Point
386
Vapor Pressure
5E-7 (25 C)
Density
0.8602 g/cm3 (55.4 C)
pKa/pKb
4.78 (pKa)
Partition Coefficient
9.82
Heat Of Vaporization
69.7 kJ/mol
Heat Of Combustion
-13805 kJ/mol
Usage
Ingredient in appetite depressants.
Refractive Index
1.4534 (20 C)

First Aid Measures

Ingestion
The possible benefit of early removal of some ingested material by cautious gastric lavage must be weighed against potential complications of bleeding or perforation. Activated charcoal activated charcoal binds most toxic agents and can decrease their systemic absorption if administered soon after ingestion. Activated charcoal: administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents.
Inhalation
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Skin
Remove contaminated clothing. Wash exposed area with soap and water. If symptoms persist, seek medical attention. Launder clothing before reuse.
Eyes
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.

Handling and Storage

Storage
Keep in a cool, dry location in a tightly sealed container.
Handling
Do not wear contact lenses.

Exposure Controls/Personal Protection

Personal Protection
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Respirators
NIOSH/MSHA approved respirator.
Exposure Effects
Avoid direct physical contact. Can cause eye and sking irritation. Cab be harmful fi absorbed throught the skin, inhaled or swallowed.

Fire Fighting Measures

Flash Point
350
Fire Fighting
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.

Accidental Release Measures

Small spills/leaks
Evacuate the area. Wear protective equipment. Vent area. ASweep up and place in an appropriate container to hold for disposal.

Stability and Reactivity

Stability
Stable at normal temperatures and pressures.
Incompatibilities
Strong oxidizing agents.
Decomposition
Oxides of carbon.

Hazards Identification

EC Safety Phrase
S 24/25
Contact More